Antibody-based therapeutics and vaccines are essential to combat COVID-19 morbidity and
mortality after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. …

Methods Health care workers who had previously enrolled in a hospital-wide serosurvey study,
3 conducted from July to August 2020 at the University of Maryland Medical Center, were …

There is an urgent need for an accurate antibody test for severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). We have developed 3 ELISA methods, trimer spike IgA, trimer …

Anti-HIV-1 envelope broadly neutralizing monoclonal antibodies (bNAbs) isolated from
memory B cells may not fully represent HIV-1-neutralizing profiles measured in plasma. …

Background Although there have been many studies on antibody responses to SARS-CoV-2
in breast milk, very few have looked at the fate of these in the infant, and whether they are …

Background Mycoplasma hominis, an opportunistic pathogen in human genitourinary tract,
can cause chronic infection in the prostate. Intracellular survival of M. hominis leads to a …

With much of the world infected with or vaccinated against severe acute respiratory
syndrome coronavirus 2 (commonly abbreviated SARS-CoV-2; abbreviated here SARS2), …

Coronavirus disease 2019 (COVID-19) vaccine shortages have led some experts and countries
to consider untested dosing regimens. We studied antibody responses to a single dose …

To estimate the effect of hepatitis C virus (HCV) coinfection on the development of
complications and progression of human immunodeficiency virus (HIV) disease among HIV …

HIV-1 reservoirs persist in the presence of combined antiretroviral therapy (cART). However,
cART has transformed HIV-1 infection into a chronic disease marked by control of HIV-1 …